Navigation Links
Novus Scientific Announces the World's 1st Long-Term Absorbable Mesh as an Alternative to Non-Absorbable Synthetic Mesh
Date:9/26/2011

SINGAPORE, Sept. 26, 2011 /PRNewswire/ -- Novus Scientific today announced TIGR® Matrix Surgical Mesh, the world's first and only long-term resorbable mesh, as an alternative to permanent synthetic mesh. First introduced in the US in 2010, TIGR® Matrix Surgical Mesh is currently being used in many surgical applications as an alternative to permanent synthetic mesh and expensive biologic devices.

Characteristics of TIGR® Matrix Surgical Mesh
TIGR® Matrix Surgical Mesh is knitted from two different synthetic absorbable fibers, possessing different degradation characteristics. The first fiber, making up approximately 40% of the matrix by weight, is a copolymer of glycolide, lactide, and trimethylene carbonate. The second fiber, making up approximately 60% of the matrix by weight, is a copolymer of lactide, and trimethylene carbonate. Both fibers degrade by bulk hydrolysis once implanted.

Based on the product's absorption characteristics, in vitro testing showed that the first fiber retains its functional capabilities for 1-2 weeks and in vivo studies in the abdominal wall of sheep showed that the first fiber was fully absorbed after 4 months. The same in vitro testing showed that the second fiber retains its functional capabilities for 6 months and in vivo studies in the abdominal wall of sheep indicated that the second fiber is completely absorbed after approximately 36 months.

"We at Novus Scientific have long prided ourselves on identifying clinical need and developing innovative products to address that need. We are pleased to highlight the fact that TIGR® Matrix Surgical Mesh is a viable alternative to permanent synthetic mesh on both a physiological treatment level and a budgetary level when used by physicians performing surgeries that reinforce soft tissue where weakness exists," said Thomas Engstrom, Founder and CEO of Novus Scientific.

"Surgeons want to provide the best treatment for their patients. Now, TIGR® Matrix Surgical Mesh offers surgeons an alternative to non-absorbable synthetic mesh," commented James Archetto, President of Novus Scientific, Inc.

Mark Swierzewski, MD, a urological surgeon from Tampa, FL stated, "TIGR® Matrix has been a part of my practice since 2010. It provides me and my patients with a viable alternative to non-absorbable synthetic mesh."

About Novus Scientific
Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of absorbable synthetic medical devices. Visit our PRESSROOM: http://www.mynewsdesk.com/pressroom/novus-scientific

TIGR® is a trademark of Novus Scientific Pte. Ltd

CONTACT:
jim.archetto@novusscientific.com
781-577-2599


'/>"/>
SOURCE Novus Scientific
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Novus Scientific Receives FDA Clearance for TIGR(TM) Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
2. Novus Scientific Announces the Sales Launch for TIGR™ Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
3. Novus Scientific and Singapore Association of Plastic Surgeons (SAPS) Host the Inaugural Event of SOFTISSUE - The Issue of Soft Tissue, Featuring James J. Chao, M.D., FACS, Professor of Plastic Surgery and Orthopedic Surgery, University of Califor
4. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
5. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
6. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
7. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
8. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
9. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
10. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
11. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... its meeting with the U.S. Food and Drug Administration ... At the meeting, ... for submission of ORMD-0801, would be a Biologics License ...
(Date:8/31/2017)... PM360,s annual Innovations Issue, published in ... innovations happening across the industry. Established six years ago, ... providing a comprehensive look at the newest and most ... innovative companies, startups, divisions, products, services, and strategies from ... "Everyone in this industry wants to do better—in all ...
(Date:8/28/2017)... Aesculight ®, a division of LightScalpel ®, LLC, is announcing its ... 20 years of American veterinary laser surgery innovation, Aesculight® is revolutionizing veterinary ... ... with his new VetScalpel laser. Dr. Duclos practices veterinary dermatology at the ... ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy Group is ... software, The Guard®, has helped another long-time client pass their Department of Health ... satisfy the law. , Thanks to the help of the Compliancy Group's Audit ...
(Date:9/20/2017)... ... September 20, 2017 , ... The Centers for Medicare ... Rule that it will transition to using only Worksheet S-10 to distribute Disproportionate Share ... of three live 60-minute complimentary webinars on October 17, 2017 at 2 ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... for overcoming addiction. “RECYCLED Ezekiel's Plan for Freedom from ADDICTION” is the ... extensive background in the field of addiction and homeless services, including more than ...
(Date:9/20/2017)... ... ... “The Foggy Road to Moorwick”: the adventures of a young Scottish girl yearning to see ... Liston, a busy mother of five who used her time waiting for children to finish ... over twenty years. It was a way to give some meaning to the hours ...
(Date:9/19/2017)... ... September 19, 2017 , ... Only a few physicians ... include Brevard’s own Ross A. Clevens, MD, FACS . The founder and medical ... Plastic and Reconstructive Surgeon who trained at Yale, Harvard and the University of Michigan. ...
Breaking Medicine News(10 mins):